Iambic Therapeutics
Iambic Therapeutics is seeking a Computational Chemist to apply ligand and structure-based techniques to support drug discovery across multiple indications. The role involves collaborating with machine learning scientists, medicinal chemists, and biologists to design, evaluate, and prioritize virtual libraries, integrate proprietary co‑folding technology, and deliver actionable computational insights for hit identification, lead optimization, and candidate selection.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2020
Iambic Therapeutics is a biotech company applying an AI-driven platform — including its Enchant and NeuralPLexer technologies — to tackle the most challenging design problems in drug discovery and address unmet patient needs. Its high-throughput experimental platform converts novel molecular designs into biological insights, enabling faster development of potential best-in-class and first-in-class medicines. Iambic maintains a proprietary clinical pipeline targeting cancers such as HER2-driven tumors and breast cancer, and pursues collaborations with pharmaceutical partners, including Bayer, to advance AI-driven drug discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Iambic Therapeutics.
Computational Chemist
General Proximity
Advisor of Computational Peptide Biochemistry
lifelancer
Sr/Principal Scientist, Computational Chemistry
Iambic Therapeutics
Advisor of Computational Peptide Biochemistry
Eli Lilly and Company
Scientist, Computational Medicinal Chemistry
Monte Rosa Therapeutics, Inc
Computational Chemist
Vertex